Skip to content

Brain Cancer Health Center

Font Size

Neuroblastoma Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Treatment of Intermediate-Risk Neuroblastoma

The Children's Oncology Group (COG) intermediate-risk group assignment criteria are described in Table 7.

Table 7. Children's Oncology Group (COG) Neuroblastoma Intermediate-Risk Group Assignment Schema Used for COG-P9641 and COG-A3961 Studiesa

INSS StageAgeMYCNStatusINPC ClassificationDNA Ploidyb
INPC = International Neuroblastoma Pathologic Classification; INSS = International Neuroblastoma Staging System.
a The COG-P9641 and COG-A3961 trials established the current standard of care for neuroblastoma patients in terms of risk group assignment and treatment strategies.
b DNA Ploidy: DNA Index (DI) > 1 is favorable, DI = 1 is unfavorable; hypodiploid tumors (with DI < 1) will be treated as a tumor with a DI > 1 (DI < 1 [hypodiploid] to be considered favorable ploidy).
c INSS stage 3 or stage 4 patients with clinical symptoms as listed above receive immediate chemotherapy.
d INSS stage 4S infants with favorable biology and clinical symptoms are treated with immediate chemotherapy until asymptomatic (2–4 cycles). Clinical symptoms include the following: respiratory distress with or without hepatomegaly or cord compression and neurologic deficit or inferior vena cava compression and renal ischemia; or genitourinary obstruction; or gastrointestinal obstruction and vomiting; or coagulopathy with significant clinical hemorrhage unresponsive to replacement therapy.
3c<365 dNonamplifiedAnyAny
≥365 d–21 yNonamplifiedFavorable-
4c<548 d[1,2,3]NonamplifiedAnyAny
4Sd<365 dNonamplifiedAny=1
<365 dNonamplifiedUnfavorableAny

(Refer to the Treatment of Stage 4S Neuroblastoma section of this summary for more information about the treatment of stage 4S neuroblastoma.)

Standard Treatment Options for Intermediate-Risk Neuroblastoma

Standard treatment options for intermediate-risk neuroblastoma include the following:

  1. Surgery and chemotherapy.
  2. Surgery and observation (in infants).
  3. Radiation therapy.

Surgery and chemotherapy

Patients categorized as intermediate risk have been successfully treated with surgery and four to eight cycles of chemotherapy (carboplatin, cyclophosphamide, doxorubicin, and etoposide; the cumulative dose of each agent is kept low to minimize permanent injury from the chemotherapy regimen) (COG-A3961). As a rule, patients whose tumors had unfavorable biology received eight cycles of chemotherapy, compared with four cycles for patients whose tumors had favorable biology. The COG-A3961 phase III trial demonstrated that therapy could be significantly reduced for patients with intermediate-risk neuroblastoma while maintaining outstanding survival.[4]

    1|2|3|4
    Next Article:

    Today on WebMD

    doctor and patient
    How to know when it’s time for home care
    doctory with x-ray
    Here are 10 to know.
     
    sauteed cherry tomatoes
    Fight cancer one plate at a time.
    Lung cancer xray
    See it in pictures, plus read the facts.
     
    Malignant Gliomas
    Article
    Pets Improve Your Health
    SLIDESHOW
     
    Headache Emergencies
    Video
    life after a brain tumor
    VIDEO
     

    Would you consider trying alternative or complementary therapies?